Up to one in four women with type 1 diabetes mellitus (T1DM) also have polycystic ovary syndrome (PCOS). Under subcutaneous insulin administration, systemic hyperinsulinism might trigger PCOS in women predisposed to the condition. However, very little is known about the long-term consequences of androgen excess in women with T1DM, and management guidelines are lacking.
This is a preview of subscription content, log in via an institution to check access.
References
Escobar-Morreale, H. F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270–284 (2018).
Escobar-Morreale, H. F. et al. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 85, 4182–4187 (2000).
Asuncion, M. et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85, 2434–2438 (2000).
Roldan, B. et al. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care 24, 1297–1299 (2001).
Escobar-Morreale, H. F. & Roldán-Martín, M. B. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care 39, 639–648 (2016).
Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I. & Yarali, H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 27, 3067–3073 (2012).
Dunaif, A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 18, 774–800 (1997).
Escobar-Morreale, H. F. et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin. Chem. 58, 999–1009 (2012).
Pozzilli, P. & Buzzetti, R. A new expression of diabetes: double diabetes. Trends Endocrinol. Metab. 18, 52–57 (2007).
Xu, G. et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ 362, k1497 (2018).
Acknowledgements
The authors acknowledge the support of grants PIE1600050, PI1801122 and PI2100116 from Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation. Instituto de Salud Carlos III is cofinanced by the European Development Regional Fund ‘A way to achieve Europe’. CIBERDEM and IRYCIS are also initiatives of Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
The Accu-Chek DiaPort system: https://www.accu-chek.de/de/diaport/index.html
Rights and permissions
About this article
Cite this article
Escobar-Morreale, H.F., Bayona, A., Nattero-Chávez, L. et al. Type 1 diabetes mellitus and polycystic ovary syndrome. Nat Rev Endocrinol 17, 701–702 (2021). https://doi.org/10.1038/s41574-021-00576-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-021-00576-0
- Springer Nature Limited
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.